S&P 500 retreats from record high

Posted: March 22, 2014 at 3:51 a.m.

Specialist Joseph Dreyer works at his post on the floor of the New York Stock Exchange, Friday, March 21, 2014. Signs that the U.S. economy is emerging from a winter chill drove major stock indexes higher Thursday. Investors were encouraged by an increase in manufacturing and a rise in a key index of economic indicators. (AP Photo/Richard Drew)

NEW YORK — An early surge on the stock market evaporated Friday, as healthcare stocks tugged major indexes down. Biotech companies were especially hard-hit after lawmakers questioned the pricing of a hepatitis-C drug made by Gilead Sciences.

This story is only available from our archives.

Business, Pages 28 on 03/22/2014


« Previous Story

Rising shrimp costs trouble Red Lobster

ORLANDO, Fla. — A spike in shrimp costs is causing yet more trouble for Red Lobster. Read »

Next Story »

Business news in brief

QUOTE OF THE DAY “The industry is stronger and more profitable than a year ago.” Gerard Cassidy, RBC Capital Markets banking analyst, on results of the Federal Reserve’s an... Read »